Hostname: page-component-74656f9884-8rzl6 Total loading time: 0 Render date: 2026-11-06T12:33:46.545Z Has data issue: false hasContentIssue false

Clay-Based Biohybrid Materials for Biomedical and Pharmaceutical Applications

Published online by Cambridge University Press:  01 January 2024

Eduardo Ruiz-Hitzky*
Affiliation:
Materials Science Institute of Madrid, CSIC, C/ Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain
Margarita Darder
Affiliation:
Materials Science Institute of Madrid, CSIC, C/ Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain
Bernd Wicklein
Affiliation:
Materials Science Institute of Madrid, CSIC, C/ Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain
Fidel Antonio Castro-Smirnov
Affiliation:
Universidad de las Ciencias Informáticas, Carretera a San Antonio de los Baños, km 2.5, 19370 Havana, Cuba
Pilar Aranda
Affiliation:
Materials Science Institute of Madrid, CSIC, C/ Sor Juana Inés de la Cruz 3, 28049 Madrid, Spain
Rights & Permissions [Opens in a new window]

Abstract

Clays have traditionally been linked to health care, being used for centuries in the fight against infections and diseases. Similarly, biohybrids produced by combinations of clays and biological species through ‘bottom-up’ approaches have been evaluated over the past decade for biomedical and pharmaceutical uses. These biohybrids show interesting features such as biocompatibility and biodegradability which make them suitable for healthcare applications. The aim of the present communication was to review recent research contributions describing progress and the role of biohybrid materials based on clays in biomedicine and pharmacy disciplines. Emphasis will be on the authors’ own experience of this topic, particularly on aspects related to controlled drug-delivery systems, adjuvants of vaccines, and vectors for non-viral gene transfection. Bionanocomposites offer several advantages for use in the design of new and efficient pharmacological formulations for cutaneous and oral administration. In these systems, the drug is typically entrapped in the clay and protected by a biopolymer matrix, and both components contribute to a gradual release of the drug. Clay-based hybrids have also shown their efficacy in vaccines as they can act as nanocarriers of viral particles, due to the biomimetic interface created on the clay surface after adsorption of suitable biomolecules such as phospholipids, while the clay acts as an adjuvant to increase the efficacy of the vaccine. Finally, a new application of clays as non-viral vectors for controlled gene delivery is attracting increasing interest in the treatment of diverse diseases; clays such as sepiolite have demonstrated their ability to act as nanocarriers of nucleic acids and facilitate their transfection in mammalian cells.

Information

Type
Research Article
Copyright
Copyright © Clay Minerals Society 2019
Figure 0

Fig. 1 Publications and citations from ISI-WOS database, accessed in November 2018, searched for the 2007-2017 period, involving: (a) (clay* AND (medicine* OR pharma*)) and (b) (clay* AND biohybrid* OR bionanocomposit* OR nanobiocomposit*) AND (medicine* OR pharma*), as topics, respectively.

Figure 1

Fig. 2 Biopolymers involved in the preparation of bionanocomposite materials, showing an illustrative example of each type

Figure 2

Fig. 3 Schematic representation of biohybrid beads used as drug-delivery systems, biopolymer-modified sepiolite fibers used as nanocarriers of virus particles in vaccines, and sepiolite fibers used as nanocarriers of DNA in non-viral gene therapy

Figure 3

Fig. 4 Schematic representation of the general process reported by Alcantara et al. (2010) for the preparation of microspheres of alginate–zein bionanocomposite DDS incorporating ibuprofen intercalated into a Mg-Al LDH (LDH-IBU)

Figure 4

Fig. 5 Schematic representation of the general process reported by Ribeiro et al. (2014b) for the preparation of microspheres of alginate–zein bionanocomposite DDS incorporating ibuprofen intercalated into a Mg-Al LDH (LDH-IBU)

Figure 5

Fig. 6 XRD pattern of phosphatidylcholine-montmorillonite hybrids showing the shift of the basal (001) reflection as a function of the lipid intercalation (a). Schematic illustration of the lipid intercalation in the clay interlayer space including the basal distance calculated from the XRD pattern (b). Molecular structure and drawing of phosphatidylcholine showing the zwitterionic headgroup (c)

Figure 6

Fig. 7 Immobilization of influenza A viral particles on sepiolite-lipid and Mg-Al LDH-lipid biohybrids. The white arrows in the FE-SEM images indicate the immobilized viral particles. The scale bars = 100 nm (image reproduced with permission, from (Wicklein et al. 2012)). Copyright (2012) John Wiley & Sons, Inc.

Figure 7

Fig. 8 TEM images of a set of three different V79 cells incubated with sepiolite nanofibers (a, d, and g) with progressive enlargement (×2) of internal sepiolite fibers in the respective images to the right (10 ng/μL of sepiolite in 5 × 106 cells). The arrows indicate sepiolite nanofibers embedded in membranes (Castro-Smirnov 2014). Images a, b, and c reproduced, with permission, from Castro-Smirnov et al. (2017a)

Figure 8

Fig. 9 TEM image of the sepiolite/DNA biohybrid, showing a sepiolite nanofiber with a plasmid DNA molecule adsorbed to its surface (image from O. Piétrement and F.A. Castro-Smirnov)

Figure 9

Fig. 10 Schematic representation of sepiolite-mediated DNA transfection in mammalian cells. First, the sepiolite/DNA (SEP/DNA) biohybrid is prepared by adsorption of DNA on the sepiolite nanofibers; next, the Sep/DNA biohybrid is added to the cell culture media in which mammalian cells are incubated. SEP/DNA can be internalized spontaneously into cells either by direct insertion (a), or via clathrin-mediated endocytosis (b), or via macropinocytosis (c) (from (Castro-Smirnov et al. 2017a))